Nilo Therapeutics

Harnessing neural circuits to restore immune homeostasis in disease

New York, United States · Founded 2024 · $101.0M raised

Headquarters
New York
Employees
1–10
Founded
2024
Business Model
B2B
Website
nilotx.com
Total Funding
$101.0M
Last Round
$101.0M Series AOct 2025
Rounds
1

About

Nilo Therapeutics is an early-stage biotech company developing a new class of medicines for autoimmune and inflammatory diseases by targeting the body's neural circuits that regulate immune function. Founded in 2024 by scientists from Columbia University and Yale, the company's approach harnesses neuronal-circuit modulation to restore immune homeostasis, offering a differentiated mechanism compared to existing biologics. The company launched with a $101M Series A and is headquartered in New York City.

Summary

Nilo Therapeutics is a Biotech company based in New York, United States, founded in 2024. It has raised $101.0M in total across 1 round, most recently a $101.0M Series A round in Oct 2025. Investors include The Column Group, DCVC (Data Collab) and Lux Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2025
$101.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nilo Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nilo-therapeutics"><img src="https://indexed.vc/api/badge/company/nilo-therapeutics" alt="Nilo Therapeutics on Indexed.vc" width="260" height="76" /></a>